News
Elm launched the Inner Dose Daily Skin Supplement to complement the serum. It’s meant to work from the inside out, tackling ...
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that the National Medical Products Administration of China (NMPA ...
Vyvgart and robust R&D, balanced by risks and diversification potential. Read here for more analysis of ARGX stock.
AllAfrica on MSN
Nigeria: Subnational Rivalry As a Pathway to Growth
Opinion - Real autonomy will come when states build prosperity through competition, innovation, and resilience.
In a landmark move, the US Food and Drug Administration (FDA) has given biotech company eGenesis the go-ahead to conduct a broader human trial in pig-to-human kidney transplants, marking a significant ...
Crafting a DIY fall wreath from artificial leaves and berries ensures that your fall door display lasts for years. For this ...
Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...
Stockhead on MSN
Race files key patents after major bisantrene discovery, boosting commercial prospects
Race Oncology scientists have found a way of patenting the active chemical form of its key drug candidate, bisantrene. The ...
AZoLifeSciences on MSN
How Xenotransplantation Moved From Failed Experiments To Lifesaving Reality
Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results